Effect of Duration of Symptoms on the Clinical and Functional Outcomes of Lumbar Microdiscectomy

NCT ID: NCT04538027

Last Updated: 2020-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-03

Study Completion Date

2020-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

97 patients in 3 randomized groups were treated by Microdiscectomy for lumbar disc herniation; Group A was operated at 6 weeks of symptoms, Group B at 3 months and group C at 6 months. These patients were followed for 3 years for the clinical and functional outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

150 patients were enrolled in this study and only 97 patients were finally analyzed for primary outcomes measures of Oswestry disability index and Roland-Morris Questionnaire and secondary outcome measures of Visual analogue scale for back pain and leg pain as well as length of hospital stay and time to return for daily activities. Assessments done at different periods of 2 weeks, 3 months, 6 months, 1year, 2 years and 3 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

6 weeks

Microdiscectomy was done at 6 weeks of starting symptoms

Group Type ACTIVE_COMPARATOR

Lumbar Microdiscectomy at 6 weeks of symptoms

Intervention Type PROCEDURE

Microscope assisted lumbar discectomy done at 6 weeks of starting symptoms

3 months

Microdiscectomy was done at 3 months of starting symptoms

Group Type ACTIVE_COMPARATOR

Lumbar Microdiscectomy at 3 months of symptoms

Intervention Type PROCEDURE

Microscope assisted lumbar discectomy done at 3 months of starting symptoms

6 months

Microdiscectomy was done at 6 months of starting symptoms

Group Type ACTIVE_COMPARATOR

Lumbar Microdiscectomy at 6 months of symptoms

Intervention Type PROCEDURE

Microscope assisted lumbar discectomy done at 6 months of starting symptoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lumbar Microdiscectomy at 6 weeks of symptoms

Microscope assisted lumbar discectomy done at 6 weeks of starting symptoms

Intervention Type PROCEDURE

Lumbar Microdiscectomy at 3 months of symptoms

Microscope assisted lumbar discectomy done at 3 months of starting symptoms

Intervention Type PROCEDURE

Lumbar Microdiscectomy at 6 months of symptoms

Microscope assisted lumbar discectomy done at 6 months of starting symptoms

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age more than 18 years
* Disc herniation of L3-4, L4-5 or L5-S1
* MRI showed disc protrusion or extrusion with nerve root compression corresponding to clinical features.

Exclusion Criteria

* Spondylolysis or spondylolisthesis.
* Spinal deformity like scoliosis.
* Previous spinal surgery or infection.
* Cauda equina syndrome.
* Lumbar segmental instability on dynamic radiograph: translation more than 3 mm or change in angulation more than 10 degrees
* Smoking
* Diabetes Mellitus
* Disc herniation other than levels L3-L4, L4-L5 and L5-S1
* More than single level disc hernaition.
* Body mass index 30 or more than 30
* Contained disc herniation by MRI
Minimum Eligible Age

19 Years

Maximum Eligible Age

47 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hawler Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sherwan Ahmed Ali Hamawandi

Assistant professor of orthopedic surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HMU/Sherwan11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.